ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

IOM Report: Nationwide Crisis Facing Cancer Care

September 13, 2013

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

August 26, 2005

DOD Names Innovator Award Recipients.

April 26, 2002

Young Investigators Hold Their Own

September 28, 1979

GAO Decision Clears NCI to Deploy Medidata Rave Data Capture System

June 17, 2011

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006